The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
August 29th 2025
The AI-powered cardiovascular ultrasound device reportedly offers enhanced spatial and contrast resolution as well as bolstered 4D imaging that enables improved evaluation of cardiac function for a wide range of patients.
Key Challenges with the O-RADS Ultrasound Classification System
July 27th 2022While the Ovarian-Adnexal Reporting and Data System ultrasound (O-RADS US) system provides a standardized and validated system for classification and risk stratification of ovarian and adnexal masses, a variety of clinical scenarios may prohibit or limit use of the system.
Eight Perspectives from Radiology Organizations on the Overturning of Roe v. Wade
July 2nd 2022In recently issued statements, different radiology organizations have offered perspectives on the physician-patient relationship and the potential impact of the Supreme Court’s decision to overturn Roe v. Wade.
Combatting Workplace Musculoskeletal Injuries in the Radiology Community
June 23rd 2022Recognizing the significant potential for workplace injuries in the radiology field, these authors discuss the proactive benefits of optimal positioning and disruptions of static posture as well as a heightened management awareness of ergonomic solutions and potential issues in maneuvering mobile imaging units.
Is Whole Body Imaging Warranted for Thrombocytopenia Caused by a COVID-19 Vaccine?
June 14th 2022In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.
New Study Points to Longer Duration of Axillary Lymphadenopathy After COVID-19 Vaccine
May 20th 2022While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.
ER Imaging Study Looks at Possible Complications of COVID-19 Vaccines
May 1st 2022Lung opacities/consolidation and cervical/axillary adenopathy are reportedly common findings in emergency room imaging of patients suspected of having complications related to COVID-19 vaccines, according to new research presented at the American Roentgen Ray Society (ARRS) conference.
Can Deep Learning Ultrasound Assessment be a Viable Option for Diagnosing Ovarian Cancer?
April 20th 2022A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.